Ferrer entered the generic drug market with its Tarbis brand in 2000. The objective was simple: to contribute to society by offering solutions that work towards the development of a sustainable health system. From the outset we were committed to maintaining Ferrer’s exacting quality standards in all sectors.
In order to offer cost-effective products, Ferrer has integrated the whole supply chain. We develop the raw materials, we synthesize them in our chemical plants, we carry out the pharmaceutical research and we manufacture the final drug in our pharmaceutical production facility.
This integration ensures competitive costs and, in turn, guarantees efficient solutions for our patients, for health systems and for a network of partners worldwide.